Contravisory Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-46,134	Closed	-$4.1M	–	279
2019 Q1	$4.1M	Sell	46,134 -500	-1%	-$44.4K	1.59%	31
2018 Q4	$3.97M	Buy	+46,634	New	+$3.97M	1.71%	30